Factors Associated With Benefit of Treatment of Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-Analysis

Esther J. S. Jansen(Radboud University Nijmegen), Willem P. de Boode(Radboud University Nijmegen), Peter Andriessen(Radboud University Nijmegen), Elisabeth M. W. Kooi(Radboud University Nijmegen), Wes Onland(Amsterdam UMC Location University of Amsterdam), Tim Hundscheid(Radboud University Nijmegen)
Frontiers in Pediatrics
February 9, 2021
10.3389/fped.2021.626262
Cited by 23

Related Papers

Clinical review: Update on hemodynamic monitoring - a consensus of 16
|Critical Care|2011|415
Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus
|New England Journal of Medicine|2022|195
Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants
|JAMA|2019|180
Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation
|JAMA|2019|147
Neonatal sepsis: need for consensus definition, collaboration and core outcomes
|Pediatric Research|2020|106